295 related articles for article (PubMed ID: 1691263)
1. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.
Smyth MJ; Ortaldo JR; Shinkai Y; Yagita H; Nakata M; Okumura K; Young HA
J Exp Med; 1990 Apr; 171(4):1269-81. PubMed ID: 1691263
[TBL] [Abstract][Full Text] [Related]
2. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets.
Smyth MJ; Norihisa Y; Gerard JR; Young HA; Ortaldo JR
Cell Immunol; 1991 Dec; 138(2):390-403. PubMed ID: 1834347
[TBL] [Abstract][Full Text] [Related]
3. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by monocytes of perforin production and its gene expression by human CD8+ T cells stimulated with interleukin-2.
Sugihara K; Sone S; Shono M; Nii A; Munekata M; Okumura K; Ogura T
Jpn J Cancer Res; 1992 Nov; 83(11):1223-30. PubMed ID: 1362428
[TBL] [Abstract][Full Text] [Related]
5. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo.
Nakata M; Smyth MJ; Norihisa Y; Kawasaki A; Shinkai Y; Okumura K; Yagita H
J Exp Med; 1990 Dec; 172(6):1877-80. PubMed ID: 2124255
[TBL] [Abstract][Full Text] [Related]
7. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
[TBL] [Abstract][Full Text] [Related]
9. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic effector function is present in resting peripheral T lymphocytes.
Geisberg M; Dupont B
Int Immunol; 1992 Nov; 4(11):1273-81. PubMed ID: 1472478
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
Lancki DW; Hsieh CS; Fitch FW
J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano A; Visonneau S; Clark SC; Santoli D
J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
[TBL] [Abstract][Full Text] [Related]
14. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.
Haeryfar SM; Conrad DM; Musgrave B; Hoskin DW
Immunol Cell Biol; 2005 Aug; 83(4):352-63. PubMed ID: 16033530
[TBL] [Abstract][Full Text] [Related]
15. Different signaling pathways induced by alpha-CD3 monoclonal antibody versus alloantigen on the basis of differential ornithine sensitivity.
Mehrotra nee Tandon P; Lind DS; Bear HD; Susskind BM
Cell Immunol; 1992 Aug; 143(1):41-54. PubMed ID: 1535833
[TBL] [Abstract][Full Text] [Related]
16. Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells.
Lu P; Garcia-Sanz JA; Lichtenheld MG; Podack ER
J Immunol; 1992 Jun; 148(11):3354-60. PubMed ID: 1588036
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of interleukin-1 gene expression in human CD3- large granular lymphocytes.
Galli MC; Smyth MJ; Young HA; Reynolds CW; Ortaldo JR
Cell Immunol; 1990 Nov; 131(1):184-90. PubMed ID: 2146033
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
[TBL] [Abstract][Full Text] [Related]
20. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]